Stay updated on Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.3.2 has been added. Revision: v3.3.1 has been removed.
    Difference
    0.0%
    Check dated 2025-12-01T16:17:27.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A note was added clarifying that publications are automatically filled from PubMed, and the page revision is updated to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-24T11:11:29.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added Tainan, Taiwan, 70403 as a study location and replaced the entry 'Tainan City, Taiwan, 70403' with 'Tainan, Taiwan, 70403' in the location list.
    Difference
    0.2%
    Check dated 2025-11-17T06:09:36.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The new screenshot shows only minor UI changes and updated timestamps; core study content such as Study Details, Eligibility Criteria, Interventions, and Outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T00:47:04.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Location entries for Cali, Valle del Cauca Department, Colombia (postal codes 760032 and 760042) were updated, replacing 'Santiago de Cali' with the standardized city name. This update standardizes naming without altering available sites or study procedures.
    Difference
    0.0%
    Check dated 2025-10-26T20:18:15.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Major update to core page content: adds a government funding notice and current operating status details, plus a version bump to v3.2.0; removes the previous v3.1.0 reference.
    Difference
    1%
    Check dated 2025-10-05T06:53:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.